The Wong Lab is a translational oncology laboratory at NYU Langone’s Perlmutter Cancer Center whose goal is to improve the outcomes of patients with lung cancer. The lab focuses on advancing the understanding of genetic and tumor immune alterations involved in lung tumorigenesis, pathogenesis, therapeutic targets, and drug resistance mechanisms.
Our team has been instrumental in evolving lung cancer into a genetically stratified disease and changing how patients with lung cancer are treated. The laboratory has pioneered generating and utilizing genetically engineered mouse lung cancer models to validate oncogenic drivers and test novel therapeutics against specific genetic oncogenic drivers. These preclinical models are now being used to lead the next revolution in lung cancer treatment through the combined assessment of genetics and tumor immunology.
The Wong Lab is highly collaborative and works with numerous premier academic investigators and pharmaceutical companies to discover and delineate the clinical path for novel therapeutic agents. Our investigators publish in high-impact journals such as Nature, Nature Medicine, and Cancer Cell. Recent postdoctoral fellows trained in the Wong Lab are now investigators at numerous biotech and pharmaceutical companies.
Kwok-Kin Wong, MD, PhD
The Anne Murnick Cogan and David H. Cogan Professor of Oncology, Department of Medicine
Smilow Research Building, 10th Floor
550 First Avenue, New York, NY 10016
Office Phone: 212-263-9203
Lab Phone: 212-263-7530